FOLR1
Folate receptor alpha
Also known as: FOLR, FOLR1_HUMAN, FRalpha
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15328
- Gene
- FOLR1
- Ensembl
- ENSG00000110195
- Chromosome
- 11
- Canonical length
- 257 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a member of the folate receptor family. Members of this gene family bind folic acid and its reduced derivatives, and transport 5-methyltetrahydrofolate into cells. This gene product is a secreted protein that either anchors to membranes via a glycosyl-phosphatidylinositol linkage or exists in a soluble form. Mutations in this gene have been associated with neurodegeneration due to cerebral folate transport deficiency. Due to the presence of two promoters, multiple transcription start sites, and alternative splicing, multiple transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
257 residues, UniProt reviewed canonical sequence.
>P15328|FOLR1
1 MAQRMTTQLL LLLVWVAVVG EAQTRIAWAR TELLNVCMNA KHHKEKPGPE DKLHEQCRPW
61 RKNACCSTNT SQEAHKDVSY LYRFNWNHCG EMAPACKRHF IQDTCLYECS PNLGPWIQQV
121 DQSWRKERVL NVPLCKEDCE QWWEDCRTSY TCKSNWHKGW NWTSGFNKCA VGAACQPFHF
181 YFPTPTVLCN EIWTHSYKVS NYSRGSGRCI QMWFDPAQGN PNEEVARFYA AAMSGAGPWA
241 AWPFLLSLAL MLLWLLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FOLR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 2,861 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 2,861 nTPM
- salivary gland: 207 nTPM
- lung: 182 nTPM
- fallopian tube: 176 nTPM
- kidney: 143 nTPM
- cervix: 116 nTPM
Single-cell type
- breast lactating cells: 1,704 nCPM
- fallopian tube ciliated cells: 789 nCPM
- migrating cytotrophoblasts: 547 nCPM
- cytotrophoblasts: 460 nCPM
- transitional alveolar cells: 450 nCPM
- alveolar cells type 1: 426 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 994 nTPM
- hippocampal formation: 26 nTPM
- cerebellum: 23 nTPM
- midbrain: 14 nTPM
- thalamus: 14 nTPM
- medulla oblongata: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FOLR1.
Disease | AllUniProt
Conditions FOLR1 is implicated in, by any mechanism.
- Neurodegeneration due to cerebral folate transport deficiency (NCFTD) MIM:613068
Disease | GeneticClinVar
31 pathogenic / likely-pathogenic of 291 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cerebral folate transport deficiency
- Epileptic encephalopathy
- Inborn genetic diseases
Disease | ImmuneIEDB
Conditions an epitope on FOLR1 was assayed in.
- ovarian cancer B and T cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against FOLR1 are reported. Each links to that disease's full target list.
Showing 0 of 3 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for FOLR1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
34 publications
- Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.
2018 · Mol Psychiatry · RCR 7.4 · 140 citations - Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis.
2021 · J Pers Med · RCR 5.3 · 61 citations - Folic Acid and Autism: A Systematic Review of the Current State of Knowledge.
2021 · Cells · RCR 4.6 · 51 citations - The metabolic basis for developmental disorders due to defective folate transport.
2016 · Biochimie · RCR 3.5 · 75 citations - Blocking and Binding Folate Receptor Alpha Autoantibodies Identify Novel Autism Spectrum Disorder Subgroups.
2016 · Front Neurosci · RCR 2.5 · 54 citations
Show 20 more of 34 total
- Cerebral folate transporter deficiency: a potentially treatable neurometabolic disorder.
2023 · Acta Neurol Belg · RCR 2.5 · 13 citations - Neurodevelopmental Impact of Maternal Immune Activation and Autoimmune Disorders, Environmental Toxicants and Folate Metabolism on Autism Spectrum Disorder.
2025 · Curr Issues Mol Biol · RCR 2.3 · 6 citations - Folate Receptor Alpha Autoantibodies in Autism Spectrum Disorders: Diagnosis, Treatment and Prevention.
2021 · J Pers Med · RCR 2.2 · 27 citations - Analysis of the Association Between the SLC19A1 Genetic Variant (rs1051266) and Autism Spectrum Disorders, Cerebral Folate Deficiency, and Clinical and Laboratory Parameters.
2025 · J Mol Neurosci · RCR 2.1 · 5 citations - Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder.
2020 · Semin Pediatr Neurol · RCR 2 · 32 citations - Folate Receptor Alpha Autoantibodies in the Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) Population.
2024 · J Pers Med · RCR 1.8 · 7 citations - Exposure to Folate Receptor Alpha Antibodies during Gestation and Weaning Leads to Severe Behavioral Deficits in Rats: A Pilot Study.
2016 · PLoS One · RCR 1.8 · 40 citations - Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies.
2014 · Mol Genet Metab · RCR 1.7 · 45 citations - Binding Folate Receptor Alpha Autoantibody Is a Biomarker for Leucovorin Treatment Response in Autism Spectrum Disorder.
2024 · J Pers Med · RCR 1.6 · 6 citations - Improving Outcome in Infantile Autism with Folate Receptor Autoimmunity and Nutritional Derangements: A Self-Controlled Trial.
2019 · Autism Res Treat · RCR 1.5 · 26 citations - The basis for folinic acid treatment in neuro-psychiatric disorders.
2016 · Biochimie · RCR 1.4 · 31 citations - Prevention of behavioral deficits in rats exposed to folate receptor antibodies: implication in autism.
2017 · Mol Psychiatry · RCR 1.4 · 30 citations - Absorption and Tissue Distribution of Folate Forms in Rats: Indications for Specific Folate Form Supplementation during Pregnancy.
2022 · Nutrients · RCR 1.2 · 10 citations - Folate receptor alpha autoantibodies in children with autism spectrum disorder.
2022 · Biomarkers · RCR 1.1 · 9 citations - Genetic assessment and folate receptor autoantibodies in infantile-onset cerebral folate deficiency (CFD) syndrome.
2018 · Mol Genet Metab · RCR 1 · 19 citations - Correction: Rossignol, D.A.; Frye, R.E. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. J. Pers. Med. 2021, 11, 1141.
2022 · J Pers Med · RCR 0.9 · 8 citations - Folate receptor alpha autoantibodies in the serum of patients with relapsing-remitting multiple sclerosis (RRMS).
2024 · Clin Neurol Neurosurg · RCR 0.7 · 3 citations - Folate receptor autoantibodies in pregnancy related complications.
2015 · Birth Defects Res A Clin Mol Teratol · RCR 0.7 · 16 citations - The role of folate receptor autoantibodies in preterm birth.
2015 · Nutrition · RCR 0.5 · 12 citations - Autoantibodies to folate receptor alpha during early pregnancy and risk of oral clefts in Denmark.
2010 · Pediatr Res · RCR 0.4 · 12 citations
Reference: B cellIEDB
1 publication
- Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients.
2018 · Clin Cancer Res · RCR 2.7 · 79 citations
Reference: T cellIEDB
2 publications
- Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.
2019 · Cancer Med · RCR 1.3 · 33 citations - Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development.
2017 · J Cancer · RCR 0.2 · 8 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0.13
- gnomAD missense Z
- 0.67
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterior neural tube closure
- axon regeneration
- cardiac neural crest cell migration involved in outflow tract morphogenesis
- cell adhesion
- folic acid metabolic process
- folic acid transport
- fusion of sperm to egg plasma membrane involved in single fertilization
- heart looping
- pharyngeal arch artery morphogenesis
- receptor-mediated endocytosis
- regulation of canonical Wnt signaling pathway
- regulation of transforming growth factor beta receptor signaling pathway
- sperm-egg recognition
- tetrahydrofolate biosynthetic process
- cellular response to folic acid
- neural crest cell migration involved in heart formation
Molecular functions
Cellular components
- apical plasma membrane
- basolateral plasma membrane
- brush border membrane
- cell surface
- clathrin-coated vesicle
- endoplasmic reticulum membrane
- endoplasmic reticulum-Golgi intermediate compartment membrane
- endosome
- ER to Golgi transport vesicle membrane
- external side of plasma membrane
- extracellular exosome
- Golgi membrane
- membrane
- nucleus
- plasma membrane
- transport vesicle
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FOLR1 as an antibody target. Whether an autoantibody or antibody against FOLR1 could matter depends on whether native FOLR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FOLR1 is annotated at the cell surface, where native FOLR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FOLR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...